This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Initiating Clinical Trials in the EU: Current Scenario and Upcoming Changes
Published on: Mar 4th, 2015
With 28 member states and associated countries, initiating a clinical trial in the EU is perceived by many in the industry to be a daunting challenge. Upcoming changes in the regulations will change the clinical trial approval process, and make it much easier for pharma and biotech companies.
Objectives of the session:
- Understand the current scenario for including European site(s) in your clinical trials;
- Anticipate and plan for future changes and their impact on the overall approval process and timeline.